STAGE IV OSTEOSARCOMA AJCC V7
Clinical trials for STAGE IV OSTEOSARCOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV OSTEOSARCOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV OSTEOSARCOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug shows promise for rare bone cancers
Disease control OngoingThis study tests a drug called cabozantinib in people whose osteosarcoma or Ewing sarcoma has returned or worsened after standard treatment. The drug works by blocking enzymes that help cancer cells grow and by cutting off the blood supply tumors need. The main goal is to see if …
Matched conditions: STAGE IV OSTEOSARCOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:56 UTC
-
Inhaled therapy shows promise for lung metastases
Disease control OngoingThis study tests an inhaled form of a protein called interleukin-2 (IL-2) to treat cancers that have spread to the lungs, such as melanoma, kidney cancer, and sarcoma. The goal is to find the safest dose and see if it can shrink tumors. About 70 adults with advanced cancer and lu…
Matched conditions: STAGE IV OSTEOSARCOMA AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Gene test trial aims to personalize cancer care for kids
Knowledge-focused OngoingThis study screens children and young adults (ages 1-21) with advanced solid tumors, lymphomas, or related disorders that have not responded to standard therapy. Researchers analyze the genetic makeup of each patient's tumor to find specific mutations that can be targeted by cert…
Matched conditions: STAGE IV OSTEOSARCOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 02:53 UTC